ASSESSMENT: HOW TO PERSONALIZE SECONDARY FRACTURE PREVENTION?

Background: The existing armamentarium of therapeutic options to minimise fracture risk is growing. Different therapies have different properties, and can be used for different patient targets. Objectives: To discuss data on short-term fracture risk following an index fracture, and on the short-term efficacy of different therapies. Methods: Narrative review of recent literature. Disclosure of Interests: Daniel Prieto-Alhambra Grant/research support from: Grants from Amgen, UCB Biopharma and Servier outside the submitted work, Consultant for: UCB Biopharma, Speakers bureau: Amgen DOI: 10.1136/annrheumdis-2019-eular.8564Citation: Ann Rheum Dis, volume 78, supplement 2, year 2019, page A25Session: Fracture liaison service: an opportunity for rheumatologists to focus on secondary fracture prevention (Speakers Abstracts)